Lifecome Biochemistry Co.,Ltd. (SHE:002868)

Lifecome Biochemistry Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Market Capitalization	3,617	5,239	3,104	3,261	8,144	1,692
Market Cap Growth	-11.59%	68.80%	-4.84%	-59.96%	381.32%	-17.32%
Enterprise Value	4,036	6,325	4,110	3,952	8,399	1,846
Last Close Price	23.27	33.71	19.97	21.26	53.09	11.03

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
PS Ratio	7.69	10.14	4.78	6.43	24.69	4.66
PB Ratio	49.98	80.69	-126.49	7.88	13.59	2.34
P/TBV Ratio	72.52	124.44	-	15.00	14.43	2.50
P/FCF Ratio	-	-	189.81	-	-	-
P/OCF Ratio	-	-	21.95	-	-	48.11

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
EV/Sales Ratio	8.58	12.24	6.33	7.80	25.46	5.08
EV/EBITDA Ratio	97.56	557.77	-	-	-	92.74
EV/FCF Ratio	-	-	251.38	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Debt / Equity Ratio	6.49	7.82	-38.70	2.62	0.66	0.45
Debt / EBITDA Ratio	11.34	35.37	-	-	-	16.07
Debt / FCF Ratio	-	-	58.08	-	-	-
Net Debt / Equity Ratio	5.78	6.96	-37.69	2.42	0.62	0.31
Net Debt / EBITDA Ratio	10.10	39.85	-8.12	-8.17	-7.07	11.24
Net Debt / FCF Ratio	-2.34	-2.92	56.56	-1.54	-2.54	-0.69
Asset Turnover	0.44	0.46	0.38	0.32	0.26	0.33
Inventory Turnover	4.35	5.24	5.08	4.21	5.08	5.43
Quick Ratio	0.20	0.18	0.10	0.29	0.18	0.42
Current Ratio	0.37	0.35	0.17	0.51	1.04	0.58
Return on Equity (ROE)	-	-689.73%	-228.96%	-43.93%	-18.57%	-3.55%
Return on Assets (ROA)	-1.58%	-4.66%	-7.62%	-7.49%	-5.84%	-0.78%
Return on Invested Capital (ROIC)	-6.42%	-21.81%	-25.31%	-16.08%	-12.18%	-1.74%
Return on Capital Employed (ROCE)	-14.70%	-55.10%	-84.70%	-18.60%	-15.50%	-1.60%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Earnings Yield	-2.03%	-2.66%	-14.33%	-6.80%	-1.50%	-1.54%
FCF Yield	-4.94%	-2.96%	0.53%	-19.97%	-1.80%	-19.03%
Buyback Yield / Dilution	0.51%	0.52%	-0.98%	0.20%	-0.75%	0.72%
Total Shareholder Return	0.51%	0.52%	-0.98%	0.20%	-0.75%	0.72%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error